✦ LIBER ✦

Biosimilars 101: considerations for U.S. oncologists in clinical practice

✍ Scribed by Camacho, Luis H.; Frost, Craig P.; Abella, Esteban; Morrow, Phuong K.; Whittaker, Sadie

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Considerations for safety pharmacogeneti

✍ Felix W. Frueh 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Diabetes in the elderly: considerations

✍ P. Lecomte 📂 Article 📅 2005 🏛 Masson Editeur 🌐 French ⚖ 816 KB

Considerations for the Use of Clostridia

✍ Dr W. Jung, H. Winter 📂 Article 📅 1998 🏛 Springer International Publishing AG 🌐 English ⚖ 411 KB

Quantitative sensory testing in children

✍ Patricia A. McGrath; Stephen C. Brown 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Anticoagulation Patient Self-Monitoring

✍ Dr. Edith A. Nutescu; Ms. Sacheeta Bathija; Dr. Lisa K. Sharp; Dr. Ben S. Gerber 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

Clinical considerations for the allied p

✍ Gura, Melanie T. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 33 KB